|
|
||||||||
Department of Physiology and Biophysics, State University of New York, Stony Brook, New York 11794-8661
Differentiation of Ob1771 preadipocytes to adipocytes was
characterized by morphological changes and elevated expression of the
specific marker enzyme, glycerol-3-phosphate dehydrogenase. A
differentiation response substantially more complete and rapid than
that obtained with insulin and 3,5,3'-triiodothyronine was observed with established inhibitors of adenylyl cyclases:
2',5'-dideoxyadenosine (2',5'-dd-Ado),
9-(cyclopentyl)adenine (9-CP-Ade), and 9-(arabinofuranosyl)adenine (9-Ara-Ade), coincident with decreased cellular cAMP levels. These ligands inhibit adenylyl cyclases noncompetitively, via a domain referred to as the P-site because of its requirement for an intact purine moiety. Differentiation was not induced by inosine, a nucleoside known not to act at the P-site, or by
N6-(2-phenylisopropyl)adenosine
or 1,3-diethyl-8-phenylxanthine, agonist and antagonist, respectively,
for adenosine A1 receptors. Also
ineffective were IBMX or forskolin, agents that can raise intracellular
cAMP levels. Potency of the differentiation response followed the order
2',5'-dd-Ado (1-20 µM) > 9-CP-Ade (10-100
µM) = 9-Ara-Ade (10-100 µM) >> inosine, consistent with
their potencies to inhibit adenylyl cyclases. The data suggest that
inhibition of adenylyl cyclase via the P-site and the consequent
reduction in cell cAMP levels facilitate the induction of
differentiation in Ob1771 cells. The findings raise the question
whether the known endogenous P-site ligands participate in the
differentiation response induced by hormones.
adipocytes; P-site inhibition; 2',5'-dideoxyadenosine; 9-(cyclopentyl)adenine; signal transduction; adenosine 3',5'-cyclic monophosphate
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |